Marten Visser

发表

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S

S. H. van der Burg, Gerbrand J. van der Heden van Noort, E. Wiertz, 2022, Journal for ImmunoTherapy of Cancer.

Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β.

J. V. van Dissel, E. van de Vosse, E. Verdegaal, 2013, Cytokine.

Neoantigen landscape dynamics during human melanoma–T cell interactions

T. Schumacher, S. Hadrup, J. Haanen, 2016, Nature.

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

Michael R Stratton, Arno Velds, Hergen Spits, 2014, Nature Medicine.

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study

S. H. van der Burg, M. Welters, S. Santegoets, 2020, Journal for ImmunoTherapy of Cancer.

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4

Marieke E. Ijsselsteijn, S. H. van der Burg, R. van der Breggen, 2019, Genome Medicine.

Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature

S. H. van der Burg, J. Haanen, M. van Diepen, 2017, Cancer Immunology Research.

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial

S. H. van der Burg, Marianne A. Jonker, F. Speetjens, 2020, BMJ Open.

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

S. H. van der Burg, J. Haanen, S. Osanto, 2011, Cancer Immunology, Immunotherapy.

Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment

S. H. van der Burg, G. Luyten, P. A. van der Velden, 2022, Ophthalmology science.

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma

S. H. van der Burg, E. Verdegaal, M. Visser, 2017, Cancer Immunology, Immunotherapy.

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4

Marieke E. Ijsselsteijn, S. H. van der Burg, R. van der Breggen, 2019, Genome Medicine.

Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

M. Stratton, S. Behjati, T. Schumacher, 2016, Nature Medicine.

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines

D. Filippov, H. Overkleeft, A. Valentijn, 2020, Chembiochem : a European journal of chemical biology.